The HCK/BTK inhibitor KIN-8194 is active in MYD88-driven lymphomas and overcomes mutated BTKCys481 ibrutinib resistance.
第一作者:
Guang,Yang
第一单位:
Bing Center for Waldenstrom's Macroglobulinemia.
作者:
主题词
腺嘌呤(Adenine);动物(Animals);抗肿瘤药(Antineoplastic Agents);细胞系, 肿瘤(Cell Line, Tumor);抗药性, 肿瘤(Drug Resistance, Neoplasm);女(雌)性(Female);人类(Humans);淋巴瘤(Lymphoma);小鼠, 近交NOD(Mice, Inbred NOD);小鼠, SCID(Mice, SCID);突变(Mutation);髓样分化因子88(Myeloid Differentiation Factor 88);哌啶类(Piperidines);蛋白激酶抑制剂(Protein Kinase Inhibitors);原癌基因蛋白质c-hck(Proto-Oncogene Proteins c-hck);肿瘤细胞, 培养的(Tumor Cells, Cultured);小鼠(Mice)
DOI
10.1182/blood.2021011405
PMID
34132782
发布时间
2024-02-26
- 浏览0

Blood
1966-1979页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文